Medical Center of the Rockies
Loveland, CO
Not yet accepting
MagnetisMM-15
Elranatamab Post Trial Access: An Open-Label, Single-Arm Study For Participants with Multiple Myeloma Continuing From Pfizer-Sponsored Elranatamab Clinical Studies
- Bispecific Antibody
- BCMA
- CD3
- Phase 4
Accepting patients
Early Detection Blood Tests
Blinded Reference Set for Multicancer Early Detection Blood Tests
- Observational Trial